Why did you decide to participate in the Biomapas Academy?
The first time I heard about Biomapas Academy was from a friend who was already working in the pharmacy field. She sent me an advertisement for Biomapas Academy, which highly intrigued me. As I was in my last year of life science master studies, I wanted to discover my potential career possibilities and learn more about clinical trials. Therefore, without long thinking, I filled in the application form. I was very happy to be selected from quite many applicants and be invited to attend Biomapas Academy.
How was your experience during the three months?
We had four months of weekly lectures on different topics. They were related to the organization of clinical trials, regulatory affairs and pharmacovigilance of various medical products. Biomapas experts who resented the lectures even shared their personal experience and actual practical examples with us. We have been able to get acquainted with Biomapas company and its work specifics. Here we could expand our knowledge of the pharmaceutical industry.
How do you feel after graduating from the Academy?
I feel thrilled for taking a chance to participate in this unique project. After graduating from all the courses and tasks, I was absolutely honoured to be selected as the best student of Biomapas Academy 2020 and receive a scholarship. However, I mostly appreciate the valuable knowledge and experience I believe will be helpful for my future career. I think Biomapas Academy definitely contributes to the education of young professionals and is very useful, especially for those who want to get to know their professional opportunities better.
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
Global Literature Review: Ensuring Safety through Robust Processes
Learn how our end-to-end GLR process enhances patient safety and supports regulatory compliance worldwide.
Site Startup Services in Clinical Trials: Leveraging Local Expertise
Learn how integrating site startup services within a flexible FSP model accelerates activation in CIS and CEE, reduces contract cycles, and improves predictability from first submission to first patient in.
Pharmacovigilance outsourcing for boosting compliance and safety for biotech companies
Explore why pharmacovigilance outsourcing is essential for biotech companies in 2025 to ensure compliance and patient safety.
Local Affiliate Services That Deliver the Best Results
Find out how local affiliate services can reduce compliance risks and support effective regulatory strategies in the pharma industry.
The Perfect Partnership: How Mid-Sized CROs and Site Networks Deliver Clinical Trial Success
In this webinar, learn how the right size of CRO and the right type of site network partnership can deliver clinical trial success.
Breaking the Silos Across Medical Information & Pharmacovigilance – Leveraging Technology for Operational Efficiency
This whitepaper shows how a PV/MI Single Source of Truth boosts data management, compliance, and efficiency for complex therapies.
Harmonizing Product Information Across Baltic Markets
Navigating multilingual product information across several markets can be complex – but it doesn’t have to be. In this case study, we share how one of our partner companies successfully harmonized their SmPC, PIL, and labelling across the Baltic region, working with...
Dossier Transformation for Market Expansion
Struggling with outdated dossiers and complex regulatory requirements? We partnered with a large pharma company to transform a fragmented legacy submission into a fully CTD-compliant dossier for successful market expansion in Europe. In this case study, we break down...
Whitepaper: Computerised System Validation & Pharmacovigilance
This whitepaper explores how optimised computer system validation (CSV) strategies strengthen risk management, ensure data integrity in pharmacovigilance systems, and support compliance through a real-world cloud-based safety database case study.
Unlock Trial Success with the FSP Hybrid Model
Learn how the FSP hybrid model combines the best of FSO and FSP in clinical trials, enhancing operational control and flexibility.
